Loading organizations...
Loading organizations...
Developing a novel antibiotic formulation for resistant infections.
Cardeas Pharma has raised $34.0M across 1 funding round.
Cardeas Pharma has raised $34.0M in total across 1 funding round.
Cardeas Pharma has raised $34.0M in total across 1 funding round.
Cardeas Pharma's investors include Aaron Davidson, Avalon Ventures, Delphi Ventures, Devon Park Bioventures, Novo Holdings, WRF Capital.
Cardeas Pharma has raised $34.0M across 1 funding round. Most recently, it raised $34.0M Series B in May 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 23, 2013 | $34.0M Series B | Aaron Davidson | Avalon Ventures, Delphi Ventures, Devon Park Bioventures, Novo Holdings, WRF Capital |